Ship Healthcare Holdings (3360) AI Stock Analysis

• Market Cap: $185.94B
• Dividend Yield: 2.7%
• Average Volume (3M): 333.91K
• Price to Earnings (P/E): 14.3
• Beta (1Y): 0.45
• Revenue Growth: 7.28%
• EPS Growth: 1.72%
• Country: JP
• Employees: 7,793
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 21.54
• Shares Outstanding: 94,350,136
• 10 Day Avg. Volume: 368,140
• 30 Day Avg. Volume: 333,910
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.73
• Enterprise Value/Revenue: 0.20
• Enterprise Value/Gross Profit: 2.04
• Enterprise Value/Ebitda: 4.07
• 1Y Price Target: $2,649.48
• Price Target Upside: 22.24% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 76 Outperform
• Price Target: ¥2,213.00 ▲(2.10% Upside)

Ship Healthcare Holdings has a solid overall stock score driven by strong financial performance and favorable technical indicators. The valuation also supports the score, with a reasonable P/E ratio and a good dividend yield. The exclusion of the earnings call and corporate events results in a more weighted focus on these aspects.

Ship Healthcare Holdings Business Overview & Revenue Model

Company Description

Ship Healthcare Holdings (3360) is a Japanese company primarily engaged in the healthcare sector. The company operates across various segments, including medical equipment sales, hospital services, and facility management. Ship Healthcare Holdings offers comprehensive solutions that cover the sale and leasing of medical equipment, hospital facility management, and the provision of medical services. The company's mission is to enhance healthcare infrastructure and services through its integrated offerings, which encompass consulting, construction, and operational support for healthcare institutions.

How the Company Makes Money

Ship Healthcare Holdings generates revenue through multiple streams within the healthcare industry. The company earns income from the sale and leasing of medical equipment to hospitals and healthcare facilities, which forms a significant portion of its revenue. Additionally, the company provides hospital management services, including facility management and operational consulting, which contributes to its earnings. Ship Healthcare Holdings also engages in construction and renovation projects for healthcare facilities, further diversifying its revenue. Key partnerships with medical institutions and technology providers enhance its service offerings and support revenue growth by leveraging collaborative ventures. These diversified offerings allow the company to sustain its financial performance in a dynamic healthcare market.

Ship Healthcare Holdings Financial Statement Overview

Summary

Ship Healthcare Holdings demonstrates strong financial performance with consistent revenue growth, stable profit margins, and effective cash flow management. The reduction in leverage and improved return on equity further enhance its financial stability, despite a slight decrease in cash reserves.

Income Statement

Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.

Balance Sheet

The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.

Cash Flow

Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	678.23B	630.99B	572.28B	514.35B	497.16B
Gross Profit	66.74B	65.61B	60.62B	53.64B	54.49B
EBITDA	32.19B	29.75B	28.61B	26.23B	26.30B
Net Income	15.13B	13.79B	12.06B	12.17B	12.28B
Balance Sheet
Total Assets	381.70B	386.82B	381.98B	335.07B	334.50B
Cash, Cash Equivalents and Short-Term Investments	77.50B	85.07B	83.94B	77.44B	77.26B
Total Debt	37.34B	57.93B	73.94B	61.22B	64.96B
Total Liabilities	231.42B	244.60B	250.86B	212.76B	219.40B
Stockholders Equity	149.08B	139.52B	128.04B	118.29B	111.44B
Cash Flow
Free Cash Flow	16.56B	28.09B	10.20B	8.96B	14.76B
Operating Cash Flow	20.38B	31.61B	14.11B	12.43B	19.77B
Investing Cash Flow	-4.03B	-7.20B	-6.77B	-3.87B	-19.29B
Financing Cash Flow	-24.62B	-20.48B	-1.02B	-8.84B	-10.46B

Ship Healthcare Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2167.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Positive. The current price of 2167.5 is above the 20-day moving average (MA) of 2117.13, above the 50-day MA of 2019.34, and above the 200-day MA of 2034.99, indicating a bullish trend. The MACD of 45.10 indicates Positive momentum. The RSI at 55.84 is Neutral, neither overbought nor oversold. The STOCH value of 57.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	79 Outperform	¥143.13B	17.52	6.38%	3.67%	2.72%	-6.31%
3360	76 Outperform	$185.94B	14.30	10.03%	2.70%	7.28%	1.72%
7716	75 Outperform	¥175.51B	34.05	4.39%	2.56%	10.98%	-76.45%
7730	72 Outperform	¥126.40B	23.15		3.04%	5.82%	-20.09%
3593	69 Neutral	¥74.92B	93.20	1.63%	1.66%	-0.91%	-52.71%
Sector *	65 Neutral	¥341.94B	11.51	-0.17%	2.40%	9.60%	-10.22%
8086	57 Neutral	¥240.24B	41.72	2.49%	2.16%	8.83%	-40.24%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Holdings Reports Increased Sales but Declining Profits in Q1 2025

Ship Healthcare Holdings reported a 5.2% increase in net sales for the three months ending June 30, 2025, compared to the same period in 2024. However, the company experienced declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 15.8%, 31.0%, and 34.1%, respectively. The financial results indicate challenges in profitability despite increased sales, which may impact the company’s market positioning and stakeholder confidence.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Treasury Share Acquisition

Ship Healthcare Holdings, Inc. has announced the acquisition of 720,800 treasury shares in July 2025, as part of its ongoing share buyback program. This strategic move, conducted through the Tokyo Stock Exchange, aims to enhance shareholder value and optimize the company’s capital structure, reflecting its commitment to financial stability and market confidence.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Acquires Treasury Shares to Enhance Market Position

Ship Healthcare Holdings, Inc. has announced the acquisition of 260,000 treasury shares in June 2025, valued at approximately 500.6 million yen. This move is part of a broader strategy authorized by the Board of Directors to acquire up to 3.3 million shares, with a total potential expenditure of 5 billion yen, aimed at strengthening the company’s market position and optimizing shareholder value.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Treasury Shares Cancellation

Ship Healthcare Holdings, Inc. has announced the cancellation of 7,319,266 treasury shares, representing 7.20% of its total shares, as part of a strategic move to optimize its capital structure. This cancellation, scheduled for June 30, 2025, will result in the company having no treasury shares, potentially enhancing shareholder value and improving financial metrics.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Share Buyback Plan

Ship Healthcare Holdings has announced a plan to acquire up to 3,300,000 of its own shares, valued at up to 5 billion yen, as part of its medium-term management plan. This move aims to enhance shareholder returns, improve earnings per share, and achieve a targeted return on equity of 12%, reflecting the company’s strategic focus on balancing growth investments with shareholder returns.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.